Teva Pharmaceutical Industries Limited

Marina Zholkovsky

Anton Frenkel

Ramy Lidor-Hadas

Tamas Koltai

Muhammad Safadi

Rachel Cohen

Eliezer Bahar

Danit Licht

Michal Keisar

Daniella Licht

Fanny Caciularu

Roman Stonis

Tomas Andrysek

Marie Elblova

The subject invention provides R(+)-N-formyl-propargyl-aminoindan and a composition containing N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof, and a compound of R(+)-N-formyl-propargyl-aminoindan.

R(+)-N-formyl-propargyl-aminoindan

The subject invention provides R(+)-N-methyl-propargyl-aminoindan or a pharmaceutically acceptable salt thereof and a composition containing R(+)-N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof, and a compound of R(+)-N-methyl-propargyl-aminoindan or a salt thereof.

R(+)-N-methyl-propargyl-aminoindan

Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.

Delayed release rasagiline citrate formulation

Growing community of inventors

Bat Yam, Israel

Marina Zholkovsky